SCHEMBL8043552

SCHEMBL8043552

[CH2]CCc1ccc(-c2ccsc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.53
CYP11B1 P15538 1/20 0.53
CYP11B2 P19099 1/20 0.53
CYP2A6 P11509 5/20 0.48
CYP2B6 P20813 3/20 0.48
CYP2E1 P05181 2/20 0.48
KCNH2 Q12809 1/20 0.41
LTA4H P09960 2/20 0.40
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
PRMT6 Q96LA8 1/20 0.38
GRIA4 P48058 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CNR1 P21554 1/20 0.35
ACMSD Q8TDX5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8343615 0.83 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL16104509 0.80 CYP17A1 (0.53) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL4612023 0.80 CYP17A1 (0.53) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL27989815 0.78 CYP2A6 (0.74) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL28244556 0.77 RARB (0.50) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL5877900 0.77 CYP17A1 (0.50) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL282801 0.76
SCHEMBL8309627 0.75 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL112385 0.75 HRH3 (0.61) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL5828167 0.75 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0976744-A1 Amide, carbamate, and urea derivatives having glutamate receptor function potentiating activity ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed